Integrase inhibitors effective against human T-cell leukemia virus type 1
about
Postrenal Transplant Human T-Cell Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis: A Case Report and Review of the LiteratureNovel therapeutic strategies targeting HIV integraseNewly emerging therapies targeting viral-related lymphomas.HTLV-1-infected T cells contain a single integrated provirus in natural infectionRapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipientsThe Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug ResistanceImmune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.HIV Drug Resistance and the Advent of Integrase Inhibitors.Inflammatory manifestations of HTLV-1 and their therapeutic options.Antiviral effect of raltegravir on HTLV-1 carriers.Human T cell lymphotrophic virus 1/2 in solid organ transplantation.Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium.Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma.
P2860
Q26700149-B2636C68-9715-494B-8AB8-1D6DCBAB31CDQ27003960-BD5EEE78-94B3-48A2-A1BF-9946D21425DBQ33699201-B307961B-83DD-492B-8B57-A3CC7DCE9503Q36352523-38CF0BC9-ACF2-42AE-982C-F9D7539B0BB5Q36446222-D7033318-3CD1-4562-9E4A-A000BBADEEC8Q37288671-AD8ECA76-6E74-420E-AB05-D75C42149799Q37328362-82F4B0C9-9CB0-4737-AD39-110E866BA76CQ37945228-A9882237-5F37-4DC1-B64F-3F34E517E7EBQ38062462-41CDA117-CDB9-47D7-9F4C-A6B659FFC10FQ38262169-D07349D2-257F-4463-94E4-E4B9308FE28EQ39533380-52DB6CDD-9EA9-4667-ACE3-6EDD26ACD1F0Q42272256-42B94A83-7BF2-4905-9438-362A13B3222CQ42921947-CB240FA2-0663-449A-955C-25291D2F2771Q42977468-89135E15-CFBB-411C-BF57-99DB7FC32814Q54941716-E21EA1B2-91A1-4E9C-A35A-A7EF638DCFC9
P2860
Integrase inhibitors effective against human T-cell leukemia virus type 1
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Integrase inhibitors effective against human T-cell leukemia virus type 1
@ast
Integrase inhibitors effective against human T-cell leukemia virus type 1
@en
Integrase inhibitors effective against human T-cell leukemia virus type 1
@nl
type
label
Integrase inhibitors effective against human T-cell leukemia virus type 1
@ast
Integrase inhibitors effective against human T-cell leukemia virus type 1
@en
Integrase inhibitors effective against human T-cell leukemia virus type 1
@nl
prefLabel
Integrase inhibitors effective against human T-cell leukemia virus type 1
@ast
Integrase inhibitors effective against human T-cell leukemia virus type 1
@en
Integrase inhibitors effective against human T-cell leukemia virus type 1
@nl
P2860
P356
P1476
Integrase inhibitors effective against human T-cell leukemia virus type 1
@en
P2093
Lee Ratner
Muhammad Esa Seegulam
P2860
P304
P356
10.1128/AAC.01413-10
P407
P577
2011-02-22T00:00:00Z